Archive for 'Tag Archives: 'UCL''
International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.
Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]
iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.
The birth of a Belgian company, a joint spin-off of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute of the Université catholique de Louvain (UCL), focusing on new drug discovery, has been made [...]
Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.
UCL spin off biotechnology company Promethera Biosciences (Mont-Saint Guibert, Wallonia/Belgium), with the help and support of pharmaceutical groups and investors worldwide, is targeting a medical breakthrough with an innovative therapeutic cell product designed to treat liver [...]
Belgian biotech company, Delphi Genetics SA, launches new research project to develop antibiotic-free DNA vaccines
Using the Staby® technology, the DNAVAC research project aims to develop and produce antibiotic-free DNA vaccines that will target certain veterinary diseases. Over the next three years, Delphi Genetics will work seamlessly and in close collaboration [...]